skitahoe
12 minutes ago
They certainly could, but if their technology can actually improve DCVax-L I believe they'd do that and the improved vaccine should get a different designation, say DCVax-L2.
On the other hand, if it's not about improving DCVax-L but rather supplementing it with their product, that wo